BSW Wealth Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,655
| Closed | -$207K | – | 309 |
|
|
2024
Q3 | $207K | Sell |
2,655
-697
| -21% | -$54.3K | 0.03% | 283 |
|
|
2024
Q2 | $261K | Buy |
+3,352
| New | +$261K | 0.04% | 238 |
|
|
2023
Q4 | – | Sell |
-3,117
| Closed | -$211K | – | 275 |
|
|
2023
Q3 | $211K | Buy |
+3,117
| New | +$211K | 0.05% | 223 |
|
|
2023
Q2 | – | Sell |
-15,097
| Closed | -$1.05M | – | 284 |
|
|
2023
Q1 | $1.05M | Sell |
15,097
-1,235
| -8% | -$85.7K | 0.21% | 63 |
|
|
2022
Q4 | $1.11M | Buy |
16,332
+2,527
| +18% | +$171K | 0.24% | 61 |
|
|
2022
Q3 | $757K | Buy |
13,805
+2,851
| +26% | +$156K | 0.19% | 71 |
|
|
2022
Q2 | $724K | Buy |
10,954
+1,295
| +13% | +$85.6K | 0.17% | 80 |
|
|
2022
Q1 | $641K | Buy |
9,659
+1,091
| +13% | +$72.4K | 0.16% | 103 |
|
|
2021
Q4 | $499K | Buy |
8,568
+722
| +9% | +$42K | 0.13% | 122 |
|
|
2021
Q3 | $471K | Buy |
7,846
+781
| +11% | +$46.9K | 0.13% | 111 |
|
|
2021
Q2 | $423K | Buy |
7,065
+1,730
| +32% | +$104K | 0.12% | 114 |
|
|
2021
Q1 | $265K | Sell |
5,335
-2,622
| -33% | -$130K | 0.08% | 160 |
|
|
2020
Q4 | $398K | Buy |
7,957
+1,213
| +18% | +$60.7K | 0.12% | 98 |
|
|
2020
Q3 | $370K | Buy |
6,744
+576
| +9% | +$31.6K | 0.14% | 88 |
|
|
2020
Q2 | $326K | Buy |
+6,168
| New | +$326K | 0.11% | 92 |
|
|
2020
Q1 | – | Sell |
-9,444
| Closed | -$471K | – | 115 |
|
|
2019
Q4 | $471K | Buy |
+9,444
| New | +$471K | 0.16% | 66 |
|